908 Devices Inc. (MASS): Total Liabilities
$46.37M
As of 2025-12-31
$70.77M
As of 2026-06-30
-3.7%
3-year compound annual growth
+3.1%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $46.37M | +3.3% | 2026-03-09, Balance as of period end |
| 2024-12-31 | $44.88M | +19.7% | 2026-03-09, Balance as of period end |
| 2023-12-31 | $37.49M | -27.9% | 2025-03-07, Balance as of period end |
| 2022-12-31 | $51.99M | +12.3% | 2024-03-08, Balance as of period end |
| 2021-12-31 | $46.30M | +16.4% | 2023-03-15, Balance as of period end |
| 2020-12-31 | $39.79M | n/a | 2022-03-11, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| 908 Devices Inc. (MASS) | 2025-12-31 | $46.37M | +3.3% |
| Harvard Bioscience Inc (HBIO) | 2025-12-31 | $66.34M | +4.8% |
| Rapid Micro Biosystems, Inc. (RPID) | 2025-12-31 | $41.65M | +82.5% |
| EyePoint, Inc. (EYPT) | 2025-12-31 | $57.88M | -29.4% |
| Bionano Genomics, Inc. (BNGO) | 2025-12-31 | $29.16M | -29.4% |
| Precipio, Inc. (PRPO) | 2025-12-31 | $6.76M | +37.8% |
| Quanterix Corp (QTRX) | 2025-12-31 | $123.04M | +60.8% |
| Pacific Biosciences of California, Inc. (PACB) | 2025-12-31 | $778.73M | +3.3% |
| Seer, Inc. (SEER) | 2025-12-31 | $36.78M | -5.8% |
Compare MASS, HBIO, RPID, EYPT side by side · Screen every company in Laboratory Analytical Instruments ↗